New Technology Combining Bruker's MALDI-TOF/TOF with Bio-Rad's SELDI Set to Launch | GenomeWeb

This story originally ran on June 5.

Bruker and Bio-Rad Laboratories are launching a new system linking Bruker's MALDI-TOF/TOF platform with Bio-Rad's SELDI technology that is expected to enable researchers to detect a class of proteins and peptides that other technologies have tripped over.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.